Mogibacteriaceae: The Enigmatic Family at the Crossroads of Oral and Gut Health

The family Mogibacteriaceae represents a group of enigmatic, strictly anaerobic, Gram-positive bacteria that occupy specialized niches in the human body, primarily the oral cavity and the gastrointestinal tract. Unlike the beneficial keystone species profiled in previous monographs, Mogibacteriaceae species exhibit a complex duality: they are commensal members of the healthy microbiome yet show consistent associations with inflammatory and metabolic diseases when present in elevated abundance. This family, proposed in 2020, comprises several genera including Mogibacterium, the type genus, along with Baileyella and Hornefia.

Members of this family are characterized by their fastidious growth requirements, their role as butyrate producers in some contexts, and their emerging association with conditions ranging from obesity and periodontal disease to rheumatoid arthritis and multidrug-resistant organism colonization. Research from 2025 continues to illuminate the dual role of these organisms, revealing that while they may contribute to gut health in balanced conditions, their overabundance serves as a marker of dysbiosis and metabolic dysfunction. The family's taxonomic status remains in flux, with recent genomic analyses suggesting reclassification within the order Eubacteriales.

---

Where It Is Found

Mogibacteriaceae species occupy distinct anatomical niches in humans and other mammals, with a primary presence in the oral cavity and secondary colonization of the intestinal tract.

Oral Cavity (Primary Niche)

The oral cavity represents the primary habitat for Mogibacteriaceae, where multiple species have been isolated from dental plaque and tongue surfaces.

· Dental Plaque: Mogibacterium diversum and Mogibacterium neglectum were first isolated from human tongue plaque and periodontal pockets, establishing the oral cavity as the defining ecological niche for this family. These organisms thrive in the anaerobic subgingival environment, where they form part of the complex biofilm communities associated with both health and disease.

· Periodontal Tissues: Species including Mogibacterium timidum, Mogibacterium pumilum, and Mogibacterium vescum have been isolated from infected oral cavities, with prevalence increasing in periodontal disease states. Their presence in diseased sites suggests they may contribute to pathogenesis under conditions of dysbiosis.

Gastrointestinal Tract

Mogibacteriaceae members colonize the intestinal tract, particularly the colon and cecum, though their abundance varies significantly based on host health status.

· Colonic Niche: In healthy individuals, Mogibacteriaceae represent a minor component of the gut microbiota. However, their abundance increases in various disease states, including obesity, metabolic syndrome, and following antibiotic disruption of the gut ecosystem.

· Cecal Colonization: Studies in animal models demonstrate that Mogibacterium species can colonize the cecum, where their abundance is modulated by dietary factors. Butyrate supplementation in calves reduced cecal Mogibacterium abundance, suggesting dietary interventions can suppress these organisms.

Animal Reservoirs

Mogibacteriaceae have been detected in the gastrointestinal tracts of various mammals.

· Livestock: These organisms are present in the intestinal microbiota of cattle and pigs, providing models for studying their ecological roles and responses to dietary interventions.

· Rodents: Laboratory mice harbor Mogibacteriaceae species, enabling mechanistic studies of their effects on host metabolism and immunity.

Factors Affecting Abundance

The abundance of Mogibacteriaceae is dynamic and influenced by multiple factors.

· Diet: High-fat diets and Western dietary patterns are associated with increased Mogibacteriaceae abundance, linking these organisms to metabolic dysfunction.

· Antibiotic Exposure: Broad-spectrum antibiotics can disrupt the gut ecosystem, sometimes leading to overgrowth of Mogibacteriaceae in the post-antibiotic period.

· Disease States: Obesity, rheumatoid arthritis, psoriasis, and periodontal disease show consistent enrichment of Mogibacteriaceae species.

· Age: Colonization patterns may shift with age, though specific age-related dynamics require further investigation.

---

1. Taxonomic Insights

Scientific Name: Family Mogibacteriaceae Wylensek et al. 2020

Type Genus: Mogibacterium Nakazawa et al. 2000

Phylum: Bacillota (formerly Firmicutes)

Class: Clostridia

Order: Eubacteriales (formerly Clostridiales)

Taxonomic Status and Nomenclatural Notes

The family Mogibacteriaceae was proposed in 2020 by Wylensek and colleagues based on phylogenetic analysis of isolates from the pig intestine. However, the name has not been validly published under the International Code of Nomenclature of Prokaryotes, meaning it currently lacks standing in nomenclature.

· Synonym Status: Mogibacteriaceae is now considered a synonym of Anaerovoracaceae Chuvochina et al. 2024, which has been validly published. The type genus Mogibacterium has been placed within the family Anaerovoracaceae in recent taxonomic revisions.

· Etymology: The name derives from the type genus Mogibacterium, which itself honors an unidentified person or concept, combined with the suffix -aceae denoting a family.

· Taxonomic History: Prior to the establishment of the genus Mogibacterium in 2000, many members were classified within the genus Eubacterium, a broad and heterogeneous repository for anaerobic Gram-positive rods that lacked clear taxonomic placement.

Genus Mogibacterium: The Type Genus

The genus Mogibacterium was established in 2000 by Nakazawa and colleagues to accommodate several species previously misclassified within Eubacterium.

· Mogibacterium diversum: One of the originally described species, with type strain HM-7 isolated from human tongue plaque. The species name reflects its diverse metabolic capabilities.

· Mogibacterium neglectum: Another founding species, isolated from human oral cavities and periodontal pockets. The name reflects its previously overlooked status in oral microbiology.

· Mogibacterium timidum: A species associated with periodontal disease, isolated from infected oral sites.

· Mogibacterium pumilum: A species with small cell dimensions, isolated from human oral cavities.

· Mogibacterium vescum: A species characterized by its small size and association with oral infections.

Genomic Insights

The genome of Mogibacterium diversum strain CCUG 47132 has been completely sequenced, providing insights into its metabolic capabilities and pathogenic potential.

· Genome Size and Structure: The genome is approximately 2.7 to 3.0 Mbp in size, with a G+C content of 42 mol percent, consistent with other members of the Clostridia class.

· Metabolic Capabilities: Genomic analysis reveals pathways for carbohydrate fermentation and short-chain fatty acid production, including butyrate synthesis in some strains.

· Sporulation Potential: Genome-based predictions indicate that Mogibacterium diversum may be capable of spore formation, with 93 percent confidence in sporulation potential. This may contribute to its persistence in the environment and resilience under stress conditions.

· Oxygen Sensitivity: Genomic features confirm strict anaerobic requirements, with absence of genes for oxygen detoxification pathways.

Family Characteristics

The Mogibacteriaceae (now Anaerovoracaceae) are characterized by several defining features.

· Morphology: Rod-shaped cells occurring singly, in pairs, or in short chains.

· Gram Staining: Gram-positive, though some species may stain variably in older cultures.

· Oxygen Requirements: Strictly anaerobic, requiring oxygen-free environments for growth.

· Metabolic Profile: Chemo-organotrophic, deriving energy from carbohydrate fermentation. Many species produce butyrate and other short-chain fatty acids.

· Habitat Specialization: Adapted to mucosal surfaces, particularly the oral cavity and intestinal tract, where they occupy anaerobic niches.

Related Families and Genera

Within the order Eubacteriales, Mogibacteriaceae shares phylogenetic relationships with several other families.

· Anaerovoracaceae: The validly published name that now encompasses Mogibacteriaceae members.

· Lachnospiraceae: A family of butyrate-producing bacteria that includes many beneficial commensals, often inversely correlated with Mogibacteriaceae in disease states.

· Peptostreptococcaceae: Another family of anaerobic Gram-positive cocci and rods, sometimes co-enriched with Mogibacteriaceae in clinical conditions.

---

2. Therapeutic Actions and Clinical Significance

Unlike the beneficial probiotics profiled in previous monographs, Mogibacteriaceae are not currently considered therapeutic organisms. Instead, their clinical significance lies in their role as biomarkers of dysbiosis and their potential contributions to disease pathogenesis.

Primary Associations

· Biomarker of metabolic dysfunction (obesity, metabolic syndrome)

· Marker of periodontal disease severity

· Indicator of gut dysbiosis following antibiotic exposure

· Potential pathogen in inflammatory conditions

Secondary Associations

· Enriched in rheumatoid arthritis patients with periodontal involvement

· Increased abundance in psoriasis

· Associated with colonization by multidrug-resistant organisms

· Marker of impaired gut health in livestock

---

3. Bioactive Components and Their Action

Research on the specific bioactive components of Mogibacteriaceae remains limited compared to well-characterized probiotics. However, several factors contribute to their biological effects.

Short-Chain Fatty Acid Production

Mogibacteriaceae species produce short-chain fatty acids, particularly butyrate, as fermentation products.

· Butyrate Production: Some Mogibacterium species generate butyrate through carbohydrate fermentation. Butyrate serves as the primary energy source for colonocytes and has anti-inflammatory properties in healthy contexts.

· Context-Dependent Effects: While butyrate is generally beneficial, excessive production or production in inappropriate anatomical sites (such as the oral cavity) may contribute to inflammation.

· Metabolic Implications: Butyrate production may influence host energy metabolism, potentially contributing to the association between Mogibacteriaceae abundance and obesity.

Lipopolysaccharide and Cell Wall Components

As Gram-positive bacteria, Mogibacteriaceae possess cell wall components that interact with host immune systems.

· Lipoteichoic Acid: Cell wall components may trigger inflammatory responses through Toll-like receptor 2 activation, potentially contributing to the pro-inflammatory associations observed in disease states.

· Peptidoglycan: Muramyl dipeptide and other peptidoglycan fragments can activate the innate immune system through NOD-like receptors.

Extracellular Vesicles

Like other Gram-positive bacteria, Mogibacteriaceae likely produce extracellular vesicles that carry bioactive molecules.

· Vesicle Cargo: Vesicles may contain proteins, enzymes, and cell wall components that interact with host cells at distant sites.

· Immune Modulation: Vesicles from oral Mogibacteriaceae may contribute to systemic inflammation in conditions like rheumatoid arthritis.

Enzymatic Activity

Mogibacteriaceae possess enzymes involved in amino acid metabolism and carbohydrate fermentation.

· Proteolytic Enzymes: Some species produce enzymes that degrade host tissues, potentially contributing to periodontal tissue destruction.

· Glycoside Hydrolases: Enzymes for breaking down host glycans may facilitate colonization of mucosal surfaces.

---

4. Clinical and Therapeutic Applications

As a Biomarker of Obesity and Metabolic Dysfunction

Recent 2025 research has established Mogibacteriaceae as a significant biomarker for obesity, particularly in pediatric populations.

· Obesity Association: In a 2025 study of Egyptian children, Mogibacteriaceae showed significantly higher abundance in obese children compared to non-obese controls. This finding places Mogibacteriaceae among a cluster of taxa including Bacilli, Clostridia, Leuconostocaceae, Klebsiella, Veillonella, Roseburia, and Anaerostipes that are enriched in obesity.

· Metabolic Dysregulation: The enrichment of Mogibacteriaceae in obese children suggests these organisms may contribute to or reflect metabolic dysfunction. Their increased abundance was observed alongside taxa associated with enhanced energy harvest capacity.

· Clinical Utility: While not yet established as a clinical biomarker, Mogibacteriaceae abundance may serve as a component of microbiome-based assessments for metabolic health, particularly in pediatric populations where obesity prevention is critical.

· Mechanistic Questions: The direction of causality remains unclear: whether Mogibacteriaceae enrichment contributes to obesity pathogenesis or merely reflects diet-induced changes in the gut ecosystem. This represents an important area for future research.

Association with Multidrug-Resistant Organism Colonization

Emerging research from 2025 has identified Mogibacteriaceae in the context of colonization by multidrug-resistant Enterobacterales.

· Transplant Patient Context: In hematopoietic stem cell transplant patients colonized by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales, Mogibacteriaceae showed greater abundance compared to non-colonized patients.

· Protective vs. Permissive Role: The relationship between Mogibacteriaceae and multidrug-resistant organism colonization is complex. In some contexts, Mogibacteriaceae may be part of a microbial community that permits or facilitates colonization by resistant pathogens.

· Clinical Implications: Understanding the microbial communities associated with multidrug-resistant organism colonization may inform strategies to prevent or decolonize these pathogens in vulnerable patient populations.

Periodontal Disease and Oral Health

The original description of Mogibacteriaceae species from oral sites established their role in periodontal disease.

· Disease Association: Mogibacterium neglectum, Mogibacterium timidum, and other species are enriched in patients with periodontitis compared to healthy controls. Their abundance correlates with clinical measures of disease severity.

· Rheumatoid Arthritis Connection: In patients with rheumatoid arthritis and worsened periodontal condition, Mogibacterium neglectum is among the taxa showing increased abundance, linking oral dysbiosis to systemic inflammatory disease.

· Pathogenic Potential: While these organisms can be present in healthy mouths, their overgrowth may contribute to tissue destruction through proteolytic enzyme production and immune activation.

Gut Health and Inflammatory Conditions

Mogibacteriaceae abundance in the gut varies with health status and dietary factors.

· Impaired Gut Health: In studies of dairy calves, Mogibacterium abundance was associated with impaired gut health. Supplementation with butyrate reduced Mogibacterium abundance while improving growth and intestinal development, suggesting these organisms may be markers of gut dysfunction.

· Inflammatory Bowel Disease: While not among the most prominently featured taxa in IBD, Mogibacteriaceae have been detected in studies of gut microbiome alterations in inflammatory conditions.

· Psoriasis Connection: Salivary microbiome studies have identified Mogibacterium neglectum among taxa increased in patients with psoriasis compared to healthy controls, suggesting links between oral microbes and systemic inflammatory skin conditions.

Potential Therapeutic Target

Rather than serving as a therapeutic agent, Mogibacteriaceae may represent a target for therapeutic suppression.

· Butyrate Supplementation: Research in calves demonstrates that dietary butyrate reduces cecal Mogibacterium abundance while improving gut health, suggesting a potential strategy for suppressing these organisms when overabundant.

· Dietary Interventions: High-fat diets and Western dietary patterns increase Mogibacteriaceae abundance, while healthier dietary patterns may suppress them.

· Probiotic Modulation: Certain probiotics, such as Lacticaseibacillus casei Zhang, may reduce Mogibacteriaceae abundance through competitive exclusion or ecosystem modulation.

---

5. Therapeutic Preparations and Formulations

Current Status

Mogibacteriaceae are not currently developed or marketed as therapeutic preparations. Unlike Akkermansia muciniphila and Adlercreutzia equolifaciens, which are positioned as next-generation probiotics, Mogibacteriaceae species are not considered beneficial organisms suitable for therapeutic administration.

Research Applications

· Strain Isolation: Type strains including Mogibacterium diversum HM-7, Mogibacterium neglectum, and others are maintained in culture collections (ATCC, JCM, CCUG, CIP) for research purposes.

· Genome Sequencing: Complete genome sequences are available for reference strains, enabling functional genomics and comparative analyses.

· Animal Model Studies: Mogibacteriaceae are studied in animal models to understand their role in obesity, gut health, and periodontal disease.

Potential for Future Development

· Biomarker Assays: The consistent association of Mogibacteriaceae with obesity and metabolic dysfunction suggests potential for developing microbiome-based diagnostic assays that include these organisms.

· Targeted Suppression: If causal roles in disease are established, strategies to specifically suppress Mogibacteriaceae may be developed.

---

6. In-Depth Mechanistic Profile and Clinical Significance

The Oral-Gut Axis: A Bridge for Inflammation

Mogibacteriaceae occupy a unique position at the intersection of oral and gut microbiology, with implications for systemic inflammation.

· Oral Reservoir: The oral cavity serves as the primary habitat, where these organisms are components of dental plaque biofilms.

· Translocation Potential: Under conditions of periodontal disease or compromised gut barrier function, oral bacteria may translocate to the intestine, potentially contributing to gut dysbiosis.

· Rheumatoid Arthritis Link: The enrichment of Mogibacterium neglectum in rheumatoid arthritis patients with periodontal disease exemplifies the oral-systemic connection. Periodontal pathogens may drive autoimmune responses through molecular mimicry or sustained immune activation.

· Psoriasis Connection: Salivary enrichment of Mogibacterium neglectum in psoriasis patients suggests that oral dysbiosis may contribute to skin inflammation, possibly through shared immune pathways or systemic dissemination of bacterial products.

Metabolic Implications: Obesity and Energy Harvest

The consistent enrichment of Mogibacteriaceae in obesity across multiple studies raises important mechanistic questions.

· Energy Harvest Hypothesis: Like other Firmicutes enriched in obesity, Mogibacteriaceae may possess enhanced capacity to extract energy from otherwise indigestible dietary components, contributing to increased energy availability for the host.

· Butyrate Paradox: While butyrate is generally considered beneficial for gut health, excessive butyrate production may contribute to obesity by increasing energy harvest. The context of butyrate production matters: production by beneficial butyrate producers like Faecalibacterium prausnitzii may have different effects than production by Mogibacteriaceae in the context of dysbiosis.

· Dietary Modulation: High-fat diets, which are strongly associated with obesity, also increase Mogibacteriaceae abundance, suggesting that dietary patterns shape the microbial community in ways that may reinforce metabolic dysfunction.

· Pediatric Obesity: The 2025 study in Egyptian children establishes that Mogibacteriaceae enrichment is detectable early in life, suggesting these organisms may be involved in the development of obesity rather than merely reflecting established disease.

Periodontal Pathogenesis: Mechanisms of Tissue Destruction

The original isolation of Mogibacteriaceae from periodontal sites points to potential pathogenic mechanisms.

· Proteolytic Activity: Some Mogibacterium species produce enzymes that degrade host proteins, including collagen and other extracellular matrix components, potentially contributing to periodontal tissue destruction.

· Immune Activation: Cell wall components may trigger inflammatory responses that, while intended to control bacterial growth, inadvertently cause tissue damage.

· Biofilm Formation: As components of dental plaque biofilms, Mogibacteriaceae may contribute to the complex polymicrobial communities that characterize periodontitis.

· Synergistic Pathogenicity: Mogibacteriaceae may act synergistically with other periodontal pathogens, such as Porphyromonas gingivalis and Tannerella forsythia, to enhance overall virulence.

Multidrug-Resistant Organism Colonization: A Marker of Dysbiosis

The association between Mogibacteriaceae and ESBL-producing Enterobacterales colonization in transplant patients illuminates broader patterns of microbiome disruption.

· Ecosystem Disruption: Mogibacteriaceae enrichment may reflect broader dysbiosis following antibiotic exposure, hospitalization, and immune suppression.

· Ecological Niches: Overgrowth of certain anaerobic bacteria may create ecological conditions that favor colonization by multidrug-resistant pathogens.

· Clinical Risk Stratification: Monitoring Mogibacteriaceae abundance along with other microbiome features could potentially identify patients at highest risk for multidrug-resistant organism colonization, enabling targeted infection prevention strategies.

Gut Health in Livestock: Translational Insights

Studies in calves provide unique insights into Mogibacteriaceae biology with potential translational relevance.

· Butyrate Supplementation: Sodium-butyrate supplementation reduced cecal Mogibacterium abundance while increasing beneficial SCFA producers and improving growth performance. This suggests that dietary interventions can modulate these organisms.

· Markers of Impaired Health: Mogibacterium association with impaired gut health in livestock mirrors findings in human obesity and inflammation, suggesting conserved biological roles across mammalian hosts.

· Production Relevance: Understanding Mogibacteriaceae biology may have applications in livestock management as well as human health.

An Integrated View of Mogibacteriaceae in Health and Disease

· As Biomarkers of Metabolic Dysfunction: The consistent enrichment of Mogibacteriaceae in obesity across diverse populations and age groups positions these organisms as robust biomarkers of metabolic dysregulation. Their measurement could complement clinical assessments of metabolic health.

· As Indicators of Oral-Systemic Connections: The association of Mogibacteriaceae with periodontal disease, rheumatoid arthritis, and psoriasis highlights their potential as sentinels of oral-systemic inflammatory connections.

· As Targets for Therapeutic Suppression: Unlike beneficial bacteria that are candidates for probiotic supplementation, Mogibacteriaceae may represent targets for therapeutic suppression. Butyrate supplementation, dietary modification, and probiotic modulation offer potential strategies for reducing their abundance when overgrown.

· Taxonomic Ambiguity: The unresolved taxonomic status of Mogibacteriaceae reflects broader challenges in microbial taxonomy. The recent reclassification within Anaerovoracaceae underscores the dynamic nature of bacterial systematics and the importance of ongoing revision.

· Research Gaps: Critical gaps remain in understanding Mogibacteriaceae biology, including the direction of causality in obesity associations, the specific pathogenic mechanisms in periodontal disease, and the potential for beneficial effects in some contexts.

---

7. Dietary Strategies to Modulate Mogibacteriaceae

Purpose: To reduce Mogibacteriaceae abundance when overgrown in the context of obesity or other inflammatory conditions.

Increase Dietary Butyrate or Butyrate Precursors

Research in animal models demonstrates that butyrate supplementation reduces Mogibacterium abundance.

· Sources: Butyrate can be obtained from butter and other dairy products, though concentrations are modest. More effectively, dietary fibers that promote butyrate production by beneficial bacteria may suppress Mogibacteriaceae through ecosystem modulation.

· Prebiotic Fibers: Resistant starch, inulin, and other fermentable fibers support beneficial butyrate producers that may competitively exclude Mogibacteriaceae.

· Supplementation: Sodium-butyrate supplements are available, though their effects on human gut Mogibacteriaceae require further study.

Adopt a Healthy, Low-Fat Dietary Pattern

High-fat diets are strongly associated with increased Mogibacteriaceae abundance and obesity.

· Mediterranean Diet: Emphasizing plant-based foods, healthy fats, and limited processed foods may reduce Mogibacteriaceae abundance.

· Fiber-Rich Foods: Vegetables, fruits, legumes, and whole grains support overall microbial diversity and may suppress dysbiotic organisms.

· Limit Saturated Fat: Reducing intake of saturated fats from red meat, processed foods, and high-fat dairy may help maintain a healthy gut ecosystem.

Consider Probiotic Supplementation

Specific probiotics may reduce Mogibacteriaceae abundance through competitive exclusion or ecosystem modulation.

· Lacticaseibacillus casei Zhang: This probiotic has been shown to enrich beneficial bacteria while potentially suppressing dysbiotic taxa.

· Multi-Strain Formulations: Composite probiotics containing multiple beneficial species may more effectively restore healthy gut ecosystem balance.

Maintain Oral Health

Given the oral habitat of Mogibacteriaceae, oral hygiene practices may influence their abundance.

· Regular Brushing and Flossing: Mechanical disruption of dental plaque reduces the biomass of oral biofilms, including Mogibacteriaceae.

· Professional Dental Care: Regular cleanings and management of periodontal disease may reduce oral Mogibacteriaceae reservoirs.

· Antimicrobial Mouthwashes: Chlorhexidine and other antiseptic mouthwashes can reduce oral bacterial loads, though their effects on specific taxa require consideration.

---

8. Foods and Factors to Limit

High-Fat Diets and Western Dietary Patterns

These dietary patterns are consistently associated with increased Mogibacteriaceae abundance and obesity.

· Mechanisms: High-fat diets alter gut permeability, promote inflammation, and create ecological conditions favoring dysbiotic organisms.

· Clinical Evidence: Across multiple studies, individuals consuming Western-style diets show higher Mogibacteriaceae abundance compared to those consuming healthier dietary patterns.

Antibiotic Overuse

Broad-spectrum antibiotics disrupt the gut ecosystem and may permit overgrowth of Mogibacteriaceae.

· Susceptibility: As Gram-positive anaerobes, Mogibacteriaceae are susceptible to many antibiotics, but post-antibiotic ecosystem disruption may create opportunities for overgrowth.

· Stewardship: Judicious antibiotic use preserves healthy gut microbial communities and may prevent dysbiosis-associated overgrowth.

Poor Oral Hygiene

Neglect of oral hygiene permits accumulation of dental plaque and overgrowth of oral Mogibacteriaceae.

· Consequences: Oral Mogibacteriaceae overgrowth may contribute to periodontal disease and potentially influence systemic inflammation.

· Prevention: Regular oral hygiene practices are essential for maintaining oral microbial balance.

---

9. Therapeutic Potential Summary

Obesity and Metabolic Syndrome

Mogibacteriaceae show consistent enrichment in obesity across pediatric and adult populations. The 2025 study in Egyptian children confirms this association, establishing the relevance across diverse populations. Their role as biomarkers may inform risk stratification and monitoring.

Periodontal Disease

Mogibacteriaceae were originally isolated from periodontal sites and remain enriched in periodontitis. Their presence correlates with disease severity, and they may contribute to tissue destruction through proteolytic enzymes and immune activation.

Rheumatoid Arthritis

In patients with rheumatoid arthritis and worsened periodontal condition, Mogibacterium neglectum is among the increased taxa. This exemplifies the oral-systemic inflammatory connection and suggests these organisms may contribute to autoimmune disease pathogenesis.

Psoriasis

Salivary enrichment of Mogibacterium neglectum in psoriasis patients extends the inflammatory associations to skin disease, highlighting the broad relevance of oral microbial balance to systemic health.

Multidrug-Resistant Organism Colonization

Enrichment in patients colonized by ESBL-producing Enterobacterales suggests Mogibacteriaceae may be markers of microbiome disruption that permits resistant pathogen colonization. This may inform infection prevention strategies.

Gut Health in Livestock

Association with impaired gut health in calves provides translational insights and suggests Mogibacteriaceae may serve as biomarkers of gut dysfunction across mammalian species.

---

10. Conclusion

Mogibacteriaceae represent a family of anaerobic, Gram-positive bacteria with a complex and evolving role in human health and disease. Their original discovery in the oral cavity established their relevance to periodontal disease, while more recent research has expanded their significance to obesity, metabolic dysfunction, and systemic inflammatory conditions.

The consistent enrichment of these organisms in obesity across diverse populations, including the 2025 study in Egyptian children, positions them as robust biomarkers of metabolic dysregulation. Their association with periodontal disease, rheumatoid arthritis, and psoriasis highlights the interconnectedness of oral and systemic health, with these organisms serving as potential sentinels of the oral-systemic axis.

The taxonomic status of Mogibacteriaceae remains in flux, with recent reclassification within Anaerovoracaceae reflecting the dynamic nature of bacterial systematics. This taxonomic uncertainty, combined with limited mechanistic understanding, underscores the need for continued research.

Unlike Akkermansia muciniphila and Adlercreutzia equolifaciens, which are positioned as next-generation probiotics, Mogibacteriaceae are not currently considered beneficial organisms suitable for therapeutic administration. Instead, they may represent targets for therapeutic suppression in the context of overgrowth and dysbiosis. Dietary strategies including butyrate supplementation, healthy dietary patterns, and probiotic interventions may modulate their abundance.

As research continues to unravel the mechanisms underlying Mogibacteriaceae associations with disease, these organisms may emerge as valuable clinical biomarkers and potentially as targets for therapeutic intervention. Their story exemplifies the complexity of the human microbiome, where organisms can be commensal in some contexts yet associated with disease in others, challenging simplistic categorizations of bacteria as either good or bad.

---

11. Reference Books for In-Depth Study

· The Human Microbiota and Chronic Disease: Dysbiosis as a Cause of Human Pathology by Luigi Nibali and Brian Henderson

· Oral Microbiology and Immunology by Richard J. Lamont, George N. Hajishengallis, and Howard F. Jenkinson

· Gut Microbiota: Interactive Effects on Nutrition and Health by Edward Ishiguro, Natasha Haskey, and Kristina Campbell

· The Microbiome in Rheumatic Diseases and Infection by Gaetane Michaud and Wilson A. Almeida da Silva

· Current research literature in journals including Cell, Nature, Science, Nature Medicine, Gastroenterology, Gut, Cell Host & Microbe, International Journal of Systematic and Evolutionary Microbiology, and Journal of Clinical Periodontology

---

12. Further Study: Microbes and Interventions That Might Interest You Due to Similar Therapeutic Properties or Associations

Lachnospiraceae

Phylum: Bacillota

Similarities: Lachnospiraceae are butyrate-producing Firmicutes that, like Mogibacteriaceae, show contrasting associations with health and disease. While some Lachnospiraceae are beneficial, others may be enriched in obesity. Understanding the strain-specific and context-dependent effects within families is crucial for interpreting microbiome studies.

Porphyromonas gingivalis

Phylum: Bacteroidota

Similarities: As a keystone periodontal pathogen, P. gingivalis shares the oral niche with Mogibacteriaceae and may act synergistically in periodontitis. Its role in systemic inflammation, including rheumatoid arthritis and cardiovascular disease, parallels the systemic associations of Mogibacteriaceae.

Faecalibacterium prausnitzii

Phylum: Bacillota

Similarities: In contrast to Mogibacteriaceae, F. prausnitzii is a beneficial butyrate producer depleted in obesity and inflammation. The opposing abundance patterns of these two Firmicutes exemplify the complexity of microbial associations with health and disease.

Butyrate Supplementation

Intervention: Short-chain fatty acid

Similarities: Research demonstrating that butyrate supplementation reduces Mogibacteriaceae abundance in calves suggests this intervention may be useful for suppressing these organisms when overgrown. Butyrate's effects on gut health are context-dependent, highlighting the importance of understanding microbial ecology.

Dietary Fiber and Prebiotics

Intervention: Prebiotic substrates

Similarities: Prebiotic fibers that support beneficial butyrate producers may indirectly suppress Mogibacteriaceae through competitive exclusion and ecosystem modulation. This approach targets the broader microbial community rather than specific organisms.

---

Disclaimer

Mogibacteriaceae are commensal bacteria with complex and context-dependent associations with health and disease. Unlike the beneficial next-generation probiotics profiled in other monographs, these organisms are not currently developed or marketed as therapeutic agents. The information presented reflects current research on their associations with various conditions and is intended for educational purposes only. This information is not a substitute for professional medical advice, and individuals concerned about their microbiome or associated health conditions should consult qualified healthcare providers.